160 related articles for article (PubMed ID: 11880472)
41. Novel Approach to Fecal Occult Blood Testing by Assay of Erythrocyte-Specific microRNA Markers.
Wu CW; Cao X; Berger CK; Foote PH; Mahoney DW; Simonson JA; Anderson BW; Yab TC; Taylor WR; Boardman LA; Kisiel JB; Ahlquist DA
Dig Dis Sci; 2017 Aug; 62(8):1985-1994. PubMed ID: 28660489
[TBL] [Abstract][Full Text] [Related]
42. [Molecular stool screening for cancer diagnosis].
Horn C; Parker D
Tidsskr Nor Laegeforen; 2007 Feb; 127(3):321; author reply 321-2. PubMed ID: 17279119
[No Abstract] [Full Text] [Related]
43. [Molecular stool screening for cancer diagnosis].
Søreide K
Tidsskr Nor Laegeforen; 2006 Oct; 126(20):2684-5. PubMed ID: 17057771
[No Abstract] [Full Text] [Related]
44. Stool DNA: a viable option for colorectal cancer screening.
Hardison DM; Shuber AP
Gastroenterology; 2005 Dec; 129(6):2128-9; author reply 2129. PubMed ID: 16344091
[No Abstract] [Full Text] [Related]
45. Current methods of colorectal cancer screening.
Willis MS; Fuda FS; Chenault CB
MLO Med Lab Obs; 2002 May; 34(5):12-6, 19; quiz 20-1. PubMed ID: 12024699
[No Abstract] [Full Text] [Related]
46. Highly methylated genes in colorectal neoplasia: implications for screening.
Zou H; Harrington JJ; Shire AM; Rego RL; Wang L; Campbell ME; Oberg AL; Ahlquist DA
Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2686-96. PubMed ID: 18086775
[TBL] [Abstract][Full Text] [Related]
47. Faecal Occult Blood Point-of-Care Tests.
Kościelniak-Merak B; Radosavljević B; Zając A; Tomasik PJ
J Gastrointest Cancer; 2018 Dec; 49(4):402-405. PubMed ID: 30232694
[TBL] [Abstract][Full Text] [Related]
48. [THE BIOMARKERS FOR TIMELY DIAGNOSTICS OF COLORECTAL CANCER].
Sokolova EA; Boyarskikh UA; Shirshova AN; Kel AE; Filipenko ML
Klin Lab Diagn; 2015 Dec; 60(12):15-23. PubMed ID: 27032247
[TBL] [Abstract][Full Text] [Related]
49. [A study on the mutation of P53 and K-ras gene in colorectal adenomas and colorectal carcinomas].
Xu W; Cheng Y; Shen XF
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):821-6. PubMed ID: 23387205
[TBL] [Abstract][Full Text] [Related]
50. [Free circulating DNA based colorectal cancer screening from peripheral blood: the possibility of the methylated septin 9 gene marker].
Tóth K; Galamb O; Spisák S; Wichmann B; Sipos F; Leiszter K; Molnár J; Molnár B; Tulassay Z
Orv Hetil; 2009 May; 150(21):969-77. PubMed ID: 19443305
[TBL] [Abstract][Full Text] [Related]
51. Molecular detection of colorectal neoplasia.
Ahlquist DA
Gastroenterology; 2010 Jun; 138(6):2127-39. PubMed ID: 20420950
[TBL] [Abstract][Full Text] [Related]
52. Molecular stool sample assays for colorectal cancer screening.
Levin B
Clin Adv Hematol Oncol; 2005 Dec; 3(12):907-8. PubMed ID: 16555429
[No Abstract] [Full Text] [Related]
53. Are we getting closer to molecular population screening for colorectal cancer?
Rennert G
J Natl Cancer Inst; 2009 Jul; 101(13):902-3. PubMed ID: 19535778
[No Abstract] [Full Text] [Related]
54. [Clinicopathological features of colorectal villous tumors].
Goto H; Oda Y; Hattori M; Goto H; Sakisaka S; Terano A
Nihon Rinsho; 2003 Sep; 61 Suppl 7():271-3. PubMed ID: 14574894
[No Abstract] [Full Text] [Related]
55. [Value of fecal and blood adenomatous polyposis coli gene and K-ras gene mutation detection in colorectal neoplasm screening].
Zhan J; Li X; Yu Z; Yuan YH; Hou J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1018-21. PubMed ID: 17666342
[TBL] [Abstract][Full Text] [Related]
56. Familial colorectal cancer screening: When and what to do?
Del Vecchio Blanco G; Paoluzi OA; Sileri P; Rossi P; Sica G; Pallone F
World J Gastroenterol; 2015 Jul; 21(26):7944-53. PubMed ID: 26185367
[TBL] [Abstract][Full Text] [Related]
57. Molecular screening: why haven't we started yet?
Villa E
Am J Gastroenterol; 1997 Dec; 92(12):2144-6. PubMed ID: 9399742
[No Abstract] [Full Text] [Related]
58. [Faecal occult blood test and mass screening for colorectal cancer].
Hiwatashi N; Shimada T
Nihon Rinsho; 2003 Sep; 61 Suppl 7():201-6. PubMed ID: 14574882
[No Abstract] [Full Text] [Related]
59. Introduction of cytogenetic tests in colorectal cancer screening.
Suceveanu AI; Suceveanu A; Voinea F; Mazilu L; Mixici F; Adam T
J Gastrointestin Liver Dis; 2009 Mar; 18(1):33-8. PubMed ID: 19337631
[TBL] [Abstract][Full Text] [Related]
60. Application of the fecal microRNA test to the residuum from the fecal occult blood test.
Yamazaki N; Koga Y; Yamamoto S; Kakugawa Y; Otake Y; Hayashi R; Saito N; Matsumura Y
Jpn J Clin Oncol; 2013 Jul; 43(7):726-33. PubMed ID: 23677957
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
